TSVT 2seventy bio Inc
Price (delayed)
$4.79
Market cap
$246.68M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.04
Enterprise value
$386.21M
Highlights
The net income has increased by 30% since the previous quarter and by 13% year-on-year
TSVT's EPS is up by 30% since the previous quarter and by 26% year-on-year
2seventy bio's quick ratio has increased by 46% from the previous quarter but it has decreased by 4.7% YoY
The equity has declined by 36% year-on-year but it is up by 13% since the previous quarter
2seventy bio's gross profit has shrunk by 77% YoY and by 47% QoQ
2seventy bio's revenue has shrunk by 70% YoY and by 38% QoQ
Key stats
What are the main financial stats of TSVT
Market
Valuations
Earnings
Shares outstanding
51.5M
Market cap
$246.68M
Enterprise value
$386.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.05
Price to sales (P/S)
5.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.75
Revenue
$44.12M
EBIT
-$156.25M
EBITDA
-$146.68M
Free cash flow
-$154.44M
Per share
Balance sheet
Liquidity
EPS
-$3.04
Free cash flow per share
-$2.96
Book value per share
$4.57
Revenue per share
$0.85
TBVPS
$9.8
Total assets
$517.9M
Total liabilities
$283.09M
Debt
$251.4M
Equity
$234.8M
Working capital
$177.67M
Debt to equity
1.07
Current ratio
4.76
Quick ratio
4.66
Net debt/EBITDA
-0.95
Margins
Efficiency
Dividend
EBITDA margin
-332.5%
Gross margin
66.4%
Net margin
-354.2%
Operating margin
-506.5%
Return on assets
-28%
Return on equity
-62.3%
Return on invested capital
-23.5%
Return on capital employed
-33.2%
Return on sales
-354.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TSVT stock price
How has the 2seventy bio stock price performed over time
Intraday
-0.21%
1 week
6.44%
1 month
0.42%
1 year
28.76%
YTD
12.18%
QTD
24.42%
Financial performance
How have 2seventy bio's revenue and profit performed over time
Revenue
$44.12M
Gross profit
$29.29M
Operating income
-$223.46M
Net income
-$156.25M
Gross margin
66.4%
Net margin
-354.2%
TSVT's net margin has shrunk by 190% YoY and by 13% QoQ
2seventy bio's gross profit has shrunk by 77% YoY and by 47% QoQ
2seventy bio's revenue has shrunk by 70% YoY and by 38% QoQ
2seventy bio's operating margin has decreased by 48% from the previous quarter
Growth
What is 2seventy bio's growth rate over time
Valuation
What is 2seventy bio stock price valuation
P/E
N/A
P/B
1.05
P/S
5.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.75
TSVT's EPS is up by 30% since the previous quarter and by 26% year-on-year
The equity has declined by 36% year-on-year but it is up by 13% since the previous quarter
TSVT's P/B is 17% above its last 4 quarters average of 0.9
TSVT's P/S is 89% above its last 4 quarters average of 3.0
2seventy bio's revenue has shrunk by 70% YoY and by 38% QoQ
Efficiency
How efficient is 2seventy bio business performance
TSVT's return on sales has dropped by 190% year-on-year and by 13% since the previous quarter
The ROIC has grown by 25% from the previous quarter
2seventy bio's ROA has increased by 24% from the previous quarter but it has decreased by 9% YoY
The ROE has contracted by 21% YoY but it has grown by 21% from the previous quarter
Dividends
What is TSVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TSVT.
Financial health
How did 2seventy bio financials performed over time
TSVT's total assets is 83% greater than its total liabilities
2seventy bio's quick ratio has increased by 46% from the previous quarter but it has decreased by 4.7% YoY
TSVT's current ratio is up by 35% from the previous quarter but it is down by 4.6% YoY
TSVT's debt is 7% higher than its equity
2seventy bio's debt to equity has increased by 49% YoY but it has decreased by 12% QoQ
The equity has declined by 36% year-on-year but it is up by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.